Earl Martin Douglas, SVP, General Counsel: Allogene Therapeutics ALLO Sell · Filed 25/02/05

Trade details

Type: Insider sale
Amount: $10,950.84
Shares · price: 6,404 sh · $1.71 a share
Held after: 587,848 sh
Stock: Allogene Therapeutics ALLO
Person: Earl Martin DouglasSVP, General Counsel
Trade date: 25/02/03
Filed: 25/02/05
Days to filing: 2 days

Sold 1.1% of holdings

Share of holding sold: 1.1%

Allogene Therapeutics trades, last 26 weeks

What else happened in Allogene Therapeutics around then

Filed or reported within 30 days of the trade day · 25/01/04~25/03/05

Earl Martin Douglas's recent trades

Earl Martin DouglasSVP, General Counsel
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$63K
29,697 sh
$63K
Filed 08/21
Traded 08/21
Earl Martin DouglasSVP, General Counsel
SellAllogene Therapeutics
Sell
Allogene Therapeutics
ALLO
$40.3K
22,900 sh
$40.3K
Filed 02/04
Traded 02/02
Earl Martin DouglasSVP, General Counsel
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$40.2K
22,900 sh
$40.2K
Filed 02/02
Traded 02/02
Earl Martin DouglasOfficer
Planned saleAllogene Therapeutics
Planned sale
Allogene Therapeutics
ALLO
$11K
6,404 sh
$11K
Filed 25/02/03
Traded 25/02/03